Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
about
Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care centerMechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology.S-adenosyl-l-methionine protection of acetaminophen mediated oxidative stress and identification of hepatic 4-hydroxynonenal protein adducts by mass spectrometryConfirming the Causative Role of Acetaminophen in Indeterminate Acute Liver Failure Using Acetaminophen-Cysteine Adducts.Prolonged Acetaminophen-Protein Adduct Elimination During Renal Failure, Lack of Adduct Removal by Hemodiafiltration, and Urinary Adduct Concentrations After Acetaminophen Overdose.Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients.Protein-Derived Acetaminophen-Cysteine Can Be Detected After Repeated Supratherapeutic Ingestion of Acetaminophen in the Absence of Hepatotoxicity.Translational biomarkers of acetaminophen-induced acute liver injuryTime course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells.Paracetamol (acetaminophen) protein adduct concentrations during therapeutic dosing.Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations.Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications.Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.Impact of perinatal exposure to acetaminophen on hepatocellular metabolic function in offspring.Acetaminophen and acetylcysteine dose and duration: past, present and future.Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients.Acetaminophen/paracetamol: A history of errors, failures and false decisions.An Immunoassay to Rapidly Measure Acetaminophen Protein Adducts Accurately Identifies Patients With Acute Liver Injury or Failure.Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure.Risk prediction of hepatotoxicity in paracetamol poisoning.Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice.Accuracy of the Structured Medication History Assessment Tool (MedHAT) Compared with Recorded Real-Time Medication Use.Acetaminophen pediatric dose selection: caregiver satisfaction regarding the antipyretic efficacy of acetaminophen in children.Detection of Acetaminophen-Protein Adducts in Decedents with Suspected Opioid-Acetaminophen Combination Product Overdose.Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro.Serum paracetamol-protein adducts in ambulatory subjects: Relationship to recent reported paracetamol use.Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.Acute hepatotoxicity associated with therapeutic doses of intravenous acetaminophen.Acetaminophen Toxicity Novel Insights into Mechanisms and Future Perspectives.
P2860
Q33561982-FF0FEB7E-ECE7-406D-B966-B0BE34BCF3A8Q33848167-9E89A940-A454-4458-9DBA-A20487236D86Q35564727-B42F6747-EF17-4C22-9754-0005A9EAB639Q35749121-515DE841-4B55-4848-A0A6-8D148E7062D8Q35749131-B3175E62-F327-4CDB-94C6-90166491EB48Q35903687-DB8837DC-4D8F-45E9-95A2-3A96E50EF690Q35991824-D83D27DA-4559-41DD-A240-531249995BD4Q36001451-1B615B71-74CD-4693-A632-FAA34FAC5A9BQ36005892-BD34636C-4EAF-4370-9E9C-E212C6658AEEQ36618136-064BE028-22A9-4A96-969E-2E9AC916B53FQ36759456-260786E2-03F2-4869-B899-54D99D3BB4D3Q36844150-35B2427A-66FB-4744-9CA8-88BA0175F078Q37004604-5908D29C-7EFB-47C0-81AF-DC7431057BFCQ37553854-12094493-C28D-442C-8A8E-4D56E2C03131Q37982762-9D2C75ED-B7A1-46E3-8D4E-38C3EF12E733Q38212434-33105EC5-22FD-45ED-B815-261A43E9E598Q38272082-52EB946B-2D72-4506-9D89-286B68D835F0Q38958100-FCEF536D-BE51-42DF-BB91-10FA091140A9Q39027620-E87A02A2-AA0C-4B77-8B33-16DC73B5D2F9Q39266595-585E362E-A380-42EA-B9CD-B454AA020AF4Q39790357-F43211EB-F922-4319-B05C-E183422FD06EQ39876632-FF28594A-2083-4BC3-8C75-AA4C423D9526Q40277660-CE3B3D77-AC21-4543-993D-73F761D73F58Q41080871-F230CC10-6377-4550-99D9-02310D23090BQ46140298-BF5C60D9-3C3B-4352-A930-7FFBD6FC3ED2Q46327411-7826B8ED-90BB-4298-9D74-844FD256B66DQ47360102-347ED129-D0D6-41C7-8883-54BBCC53C619Q47404707-CDF5A7F0-3A5A-41E1-AB30-02C106A50A61Q47604288-87CCCE37-3355-493C-AB72-745CE7A52089Q47885559-7EB2CF6A-11C8-4387-8111-806DA9C19E11
P2860
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
@ast
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
@en
type
label
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
@ast
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
@en
prefLabel
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
@ast
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
@en
P2093
P2860
P356
P1433
P1476
Acetaminophen-cysteine adducts during therapeutic dosing and following overdose.
@en
P2093
Bryan S Judge
Jody L Green
Kennon J Heard
Laura P James
Liza Zolot
Richard C Dart
Sean Rhyee
P2860
P2888
P356
10.1186/1471-230X-11-20
P577
2011-03-14T00:00:00Z
P6179
1027490311